Company Filing History:
Years Active: 2025
Title: James Frank Sampson: Innovator in Cancer Treatment
Introduction
James Frank Sampson is a notable inventor based in Medford, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative solutions for treating cancer and autoimmune diseases.
Latest Patents
Sampson holds a patent for "Anti-TNFR2 antibodies and uses thereof." This patent discloses anti-TNFR2 antibodies, therapeutic compositions that include these antibodies, and methods for utilizing them in the treatment of various medical conditions, including cancer and autoimmune diseases. His research represents a promising advancement in therapeutic options for patients.
Career Highlights
James Frank Sampson is currently associated with Merrimack Pharmaceuticals, Inc., where he continues to work on groundbreaking research in the field of cancer treatment. His expertise and innovative approach have positioned him as a key figure in the development of new therapeutic strategies.
Collaborations
Sampson has collaborated with notable colleagues, including Yu Zhou and James David Marks. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic solutions.
Conclusion
James Frank Sampson's contributions to the field of biotechnology, particularly through his patent on anti-TNFR2 antibodies, highlight his commitment to advancing cancer treatment. His work continues to inspire innovation in the medical community.